BioSpace News Archive

Amgen today announced that the United States Court of Appeals for the Federal Circuit has held in Amgen’s favor on the validity of two patents that describe and claim Enbrel® (etanercept) and methods for making it.

The hospital that is under the direction of Olegario Vázquez Aldir will soon join the Hospital Ángeles family and be located South of Mexico City.

The COVID-19 coronavirus pandemic forced oncology nurses to navigate abnormal circumstances, both at home and at work.

NeurAegis, Inc., a neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders, today announced the publication of a paper titled “Calpain-2 as a therapeutic target in repeated concussion-induced neuropathy and behavioral impairment” in Science Advances.

Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that it intends to offer and sell, subject to market and other conditions, up to 5.0 million shares of its common stock and, in lieu of common stock, to offer and sell to certain investors pre-funded warrants to purchase shares of its common stock in an underwritten public offering.

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the second quarter 2020 after the market closes on Wednesday, July 29, 2020, and will hold a conference call on the same day to discuss the results at 5:00 pm EDT.

McKesson Corporation announces changes to its reportable business structure.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS™) technology, today announced that three clinical studies demonstrating positive results across its dermatologic portfolio are available via webcast at the virtual annual conference of the American Society for Laser Medicine and Surgery (ASLMS).

Maxar Technologies (NYSE:MAXR) (TSX:MAXR), a trusted partner and innovator in Earth Intelligence and Space Infrastructure, today announced that it has completed its previously announced acquisition of 3D data and analytics firm Vricon, Inc., for approximately $140 million

The Pennant Group, Inc., the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced that it has acquired the assets of two home health agencies and two hospice agencies with multiple locations across Southeastern Idaho and Northern Utah.